Opendoor stock drops 6% to $6 as mortgage-rate bets cool; Fed meeting is next
24 January 2026
1 min read

Opendoor stock drops 6% to $6 as mortgage-rate bets cool; Fed meeting is next

New York, Jan 24, 2026, 07:27 EST — Market closed

  • Opendoor shares dropped roughly 6% on Friday, closing at $6.01.
  • Investors zeroed in on mortgage-rate cues amid uncertainty about how Washington’s mortgage-bond buying spree might shake things up.
  • The next major rate move hinges on the Federal Reserve’s meeting set for Jan. 27-28.

Opendoor Technologies shares dropped 6.4% on Friday, closing at $6.01 after fluctuating between $5.95 and $6.40 during the session. In after-hours trading, the stock hovered near $6.03, with roughly 63.9 million shares changing hands. 1

The pullback is significant since Opendoor has turned into a quick, rate-sensitive play: easing mortgage rates often boost housing demand, lifting stocks linked to home buying. But if rates hold steady, sentiment shifts sharply.

A Reuters report late Thursday found little evidence that the administration’s $200 billion mortgage-backed bond buying program has significantly cut housing costs. Joseph Brusuelas, chief economist at RSM US LLP, described the effort as “mostly an exercise in burning cash.” Patricia Zobel from Guggenheim Investments added, “It’s not clear to me how much this will materially lower housing prices for consumers.” 2

Mortgage-backed securities, or MBS, are bonds secured by home loans. The report showed the average 30-year fixed mortgage rate ended 2025 at 6.15%. It slipped to 6.06% right after the bond-buy order but crept back up to 6.09% by Thursday, according to Freddie Mac data.

Opendoor operates an online platform where homeowners sell their properties straight to the company, which then flips the homes. It also provides “capital-light” marketplace and listing services. 3

The model shines when borrowing costs drop and homes sell quickly. But it can backfire if rates climb, listings stall, or the company must slash prices to offload inventory.

The downside remains straightforward: mortgage rates stop declining, and the policy efforts on MBS purchases barely nudge yields. Should longer-term Treasury yields climb, mortgage rates could rise too, dimming the housing “green shoots” trade.

The Federal Reserve’s next key event is the meeting scheduled for Jan. 27-28. The policy decision comes out at 2:00 p.m. ET on Jan. 28, followed by a press conference at 2:30 p.m. ET. 4

Stock Market Today

Silver price rebound masks fresh stress after CME lifts margins again

Silver price rebound masks fresh stress after CME lifts margins again

7 February 2026
Spot silver surged 8.6% to $77.33 an ounce Friday after dropping below $65, but still lost over 8.7% for the week. CME Group raised margin requirements for COMEX silver futures to 18% from 15%, effective after Feb. 6. China’s UBS SDIC Silver Futures Fund hit its 10% down limit for a fifth session. Traders await key U.S. jobs and inflation data next week.
Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

7 February 2026
China’s central bank raised gold reserves for a 15th month in January, reaching 74.19 million ounces worth $369.58 billion. Gold prices swung sharply, hitting a record near $5,600 before dropping to $4,403.24. CME Group hiked COMEX gold futures margins to 9% after recent volatility. U.S. jobs and inflation data are due next week after a delay.
Amazon stock (AMZN) slides on $200 billion AI capex plan — what Wall Street watches next week

Amazon stock (AMZN) slides on $200 billion AI capex plan — what Wall Street watches next week

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company forecast 2026 capital spending would jump to $200 billion, up more than 50% from 2025. The drop came as the Dow closed above 50,000 for the first time. Amazon reported fourth-quarter net sales up 14% to $213.4 billion and operating income at $25 billion. Trading in Amazon was volatile, with 179 million shares changing hands.
ImmunityBio (IBRX) stock slides after glioblastoma update — here’s what investors watch next week
Previous Story

ImmunityBio (IBRX) stock slides after glioblastoma update — here’s what investors watch next week

Grab stock price: GoTo takeover snag puts GRAB back on traders’ screens before Monday
Next Story

Grab stock price: GoTo takeover snag puts GRAB back on traders’ screens before Monday

Go toTop